Skip to content
Screener

Baxter International BAX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period at other companies

Cineverse Corp. logo
Cineverse Corp.CNVS
250-100.0%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
38.1K
3M logo
3MMMM
91K-97.5%
Healthcare Services Group logo
Healthcare Services GroupHCSG
299K+9.1%
Jerash Holdings (US), Inc. logo
Jerash Holdings (US), Inc.JRSH
986K
Baxter International logo
Baxter InternationalBAX
4.1M+295%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$13.96B+20.8%
Enterprise value$12.17B+20.5%
P/S1.2×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod.

The source filing: Baxter International’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 4:46 PM EST
Fiscal year
FY2025
Accession
0001628280-26-007733
(options and aggregate intrinsic values in thousands)OptionsWeighted-averageexercisepriceWeighted-averageremainingcontractualterm(in years)Aggregateintrinsicvalue
Outstanding as of January 1, 202517,381$60.15
Granted1,251$31.25
Exercised
Forfeited(771)$41.84
Expired(4,106)$54.86
Outstanding as of December 31, 202513,755$60.123.95
Vested or expected to vest as of December 31, 202513,663$60.333.90
Exercisable as of December 31, 202511,932$64.093.32

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Baxter International's share-based compensation arrangement by share-based payment award, options, expirations in period?
Baxter International (BAX) reported share-based compensation arrangement by share-based payment award, options, expirations in period of 4.1M in Q4 2025.
What does share-based compensation arrangement by share-based payment award, options, expirations in period mean?
The number of stock options that reached the end of their contractual term without being exercised. These options expire worthless, effectively reducing the company's potential future share dilution.

Ask your AI about Baxter International's share-based compensation arrangement by share-based payment award, options, expirations in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude